Atlaviva, a minimally invasive implantable tibial neuromodulation (ITNM) device, is inserted near the ankle and designed to treat urge urinary incontinence (UUI).

Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among implantable tibial devices for treating UUI. The insertion process takes place in a minimally invasive procedure requiring no sedation or imaging, according to Medtronic — one of the largest medtech companies in the world.

Altaviva comes in at approximately half the length of a stick of chewing gum, according to a news release. It sits slightly below the skin and above the fascia to send electrical impulses to the tibial nerve. This process helps restore communication between the bladder and the brain to regulate bladder control.